pharma out-performance off-set medic
weak guidanc midpoint tweak
net dbt
headlin beat compon less impress
cardin total result came revenu beat estim
ep beat even driver out-performance howev bit
mix total gross profit estim despit revenu beat tax
come much lower expect medic busi particular saw challeng
come soft segment ebit well lower ebit guid full year
mid-to-high singl digit growth low-to-mid singl digit declin declin
almost first nine month fiscal year pharma segment ebit
beat straightforward like expect given out-performance
peer quarter ultim pharma perform may aid stock
underli medic driver import determin ultim stock perform
maintain under-perform rate ahead call uncertain total ebit growth
revenue/ep street gp estim
total revenu street estim
estim pharmaceut segment revenu ahead
street estim estim medic segment
revenu miss street estim adjust
ebit estim adjust ep came
street estim driven larg part revenu
beat lower sg lower tax rate
rais ep guidanc lower medic ebit outlook
compani rais ep guidanc cardin
maintain segment revenu guidanc mid-to- high singl digit
growth compani maintain medic segment revenu guidanc flat cardin
maintain pharmaceut ebit profit growth high-singl low-doubl digit
percentag declin reduc medic segment ebit profit growth mid-to-
high singl growth low mid-singl digit declin also renew contract
june
topic call
key topic call includ updat outlook brand gener price
cardin contract renew level pressur seen
independ chang cordis/th competit landscap medic
provid less neg commentari around gener sourc
comment regard gener profit import also evolv rebat
model focu comment around role distributor post-reb world
import medic segment updat cordi perform total
privat label portfolio remain import item also one cardin
publicli trade medic peer transit comment relat share gain
opportun share gain focu final one quarter left
look earli color manag expect tailwinds/headwind
potenti earli look guidanc
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
price object ep multipl five-year
averag discount incorpor margin price pressur
pharmaceut segment slow brand inflat increas competit
downstream independ buy group discount medic segment
incorpor grow risk non-tradit distributor
upsid risk po potenti volum pickup increas buyside/sellsid
spread faster-than-expect contribut recent acquir medic
busi capit deploy downsid risk po increment wors
drug price pressur increas competit creat gross profit headwind risk
amazon anoth disrupt forc enter suppli chain market lack
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
invest opinion system contain end report head fundament equiti opinion dark grey shade indic secur restrict opinion suspend medium grey
shade indic secur review opinion withdrawn grey shade indic secur cover chart current april later date indic
equiti invest rate distribut health group
equiti invest rate distribut global group
issuer invest bank client bofa merril lynch one affili within past month purpos invest rate distribut coverag univers includ stock
stock rate neutral includ hold stock rate under-perform includ sell
fundament equiti opinion opinion includ volatil risk rate invest rate incom rate volatil risk rate indic potenti
price fluctuat medium high invest rate reflect analyst assess stock absolut total return potenti ii
attract invest rel stock within coverag cluster defin three invest rate buy stock expect total
return least attract stock coverag cluster neutral stock expect remain flat increas valu less attract
buy rate stock under-perform stock least attract stock coverag cluster analyst assign invest rate consid among thing
month total return expect stock firm guidelin rate dispers shown tabl current price object stock
referenc better understand total return expect given time price object reflect analyst view potenti price appreci depreci
total return expect within period date initi rate
rate dispers guidelin coverag cluster
rate dispers may vari time time bofa merril lynch research believ better reflect invest prospect stock coverag cluster
incom rate indic potenti cash dividend same/high dividend consid secur same/low dividend consid secur pay
cash dividend coverag cluster compris stock cover singl analyst two analyst share common industri sector region classif stock
coverag cluster includ recent bofa merril lynch report referenc stock
price chart secur referenc research report avail http //pricechart baml com call mail
mlpf one affili act market maker equiti secur recommend report cardin inc
issuer within last month invest bank client mlpf and/or one affili cardin
mlpf affili receiv compens issuer non-invest bank servic product within past month cardin
issuer within last month non-secur busi client mlpf and/or one affili cardin
mlpf affili receiv compens invest bank servic issuer within past month cardin
mlpf affili expect receiv intend seek compens invest bank servic issuer affili issuer within next three month cardin
mlpf one affili will sell buy client equiti secur issuer princip basi cardin inc
issuer within last month secur busi client non-invest bank mlpf and/or one affili cardin
bofa merril lynch research personnel includ analyst respons report receiv compens base upon among factor overal profit america
corpor includ profit deriv invest bank analyst respons report may also receiv compens base upon among factor overal
profit bank sale trade busi relat class secur financi instrument analyst respons
